150
Participants
Start Date
March 16, 2022
Primary Completion Date
December 31, 2041
Study Completion Date
December 31, 2041
Caribou-sponsored investigational therapy
N/A this is an observational study
Weill Cornell Medicine, New York
Icahn School of Medicine at Mt. Sinai, New York
Montefiore Medical Center, The Bronx
University of Pennsylvania, Philadelphia
Virginia Commonwealth University, Richmond
Levine Cancer Center, Charlotte
Blood & Marrow Transplant Group of Georgia, Atlanta
Augusta University/Georgia Cancer Center, Augusta
AdventHealth Medical Group Blood & Marrow Transplant at Orlando, Orlando
University of Miami, Miami
University of Alabama, Birmingham
Sarah Cannon Research Institute - TriStar Health, Nashville
Norton Cancer Institute, Louisville
University of Kentucky, Lexington
Cleveland Clinic, Cleveland
Oncology Hematology Care, Cincinnati
University of Iowa Hospitals & Clinics, Iowa City
Medical College of Wisconsin, Milwaukee
Baylor Research Institute, Dallas
MD Anderson Cancer Center, Houston
University of Colorado, Denver
Colorado Blood Cancer Institute, Denver
Huntsman Cancer Institute at the University of Utah, Salt Lake City
Banner MD Anderson Cancer Center, Gilbert
Honor Health Research Institute, Scottsdale
University of California San Diego, La Jolla
University of California Irvine, Irvine
Fred Hutchinson Cancer Center, Seattle
Regional Cancer Care Associates - Hackensack, Hackensack
Atlantic Health System Cancer Care, Morristown
Lead Sponsor
Caribou Biosciences, Inc.
INDUSTRY